CytomX Therapeutics Inc. (CTMX)
NASDAQ · Healthcare
CytomX Therapeutics Inc. Total Liabilities 2013–2025
CytomX Therapeutics Inc. annual total liabilities history from 2014 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- CytomX Therapeutics Inc. total liabilities as of December 31, 2025: 52.6M, a 56.56% decrease year-over-year.
- CytomX Therapeutics Inc. total liabilities for 2025 were 52.6M, a 56.56% decrease from 2024.
- CytomX Therapeutics Inc. total liabilities for 2024 were 121.0M, a 51.46% decrease from 2023.
- CytomX Therapeutics Inc. total liabilities for 2023 were 249.2M, a 28.10% decrease from 2022.
- CytomX Therapeutics Inc. total liabilities for 2022 were 346.6M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| CytomX Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $53 |
| 2024 | $121 |
| 2023 | $249 |
| 2022 | $347 |
| 2021 | $340 |
| 2020 | $366 |
| 2019 | $290 |
| 2018 | $326 |
| 2017 | $328 |
| 2016 | $121 |
| 2015 | $71 |
| 2014 | $75 |
CytomX Therapeutics Inc. Total Liabilities — FAQ
CytomX Therapeutics Inc. (CTMX) total liabilities over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTMX's total liabilities history?
The chart and table above show CytomX Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.